Literature DB >> 6769808

Influence of anti-slime glycolipoprotein serum on the interaction between Pseudomonas aeruginosa and macrophages.

P F Bartell, A Krikszens.   

Abstract

Glycolipoprotein, a purified fraction of the exopolysaccharide slime of Pseudomonas aeruginosa, was identified as responsible for a number of the biological activities of viable cells, including toxicity and immunogenicity capable of stimulating protective antibody against the lethal effects of viable cells. Antiserum against glycolipoprotein also mediated the phagocytosis and subsequent killing of viable P. aeruginosa by unstimulated mouse peritoneal macrophages. In the absence of anti-glycolipoprotein serum, macrophages did not significantly reduce the number of bacteria. The presence of complement in the experimental mixture did not affect the reduction of bacteria by the macrophage in the presence of anti-glycolipoprotein serum. The limiting effect of antiserum concentration on macrophage activity was studied, and maximal activity was found at 2%, with no further increase in activity at 5% Preopsonization of the bacteria with anti-glycolipoprotein serum had little effect on the course of phagocytosis within the experimental conditions. Variations in bacterium-to-macrophage input ratios, ranging from 30:1 to 1:30, did not affect the capacity of the macrophages for phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769808      PMCID: PMC550839          DOI: 10.1128/iai.27.3.777-783.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Role of cell wall structure of salmonella in the interaction with phagocytes.

Authors:  D Friedberg; M Shilo
Journal:  Infect Immun       Date:  1970-09       Impact factor: 3.441

2.  Phagocytosis and processing of bacteria by peritoneal macrophages.

Authors:  W R Thomas; P G Holt; D Keast
Journal:  J Reticuloendothel Soc       Date:  1974-01

3.  Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum.

Authors:  B Boxerbaum; A Kagumba; L W Matthews
Journal:  Am Rev Respir Dis       Date:  1973-10

4.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

5.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

6.  Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.

Authors:  A B Bjornson; J G Michael
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

7.  Polysaccharide depolymerase associated with bacteriophage infection.

Authors:  P F Bartell; T E Orr; G K Lam
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

8.  In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.

Authors:  M Lynn; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

9.  Slime of Pseudomonas aeruginosa: in vivo production.

Authors:  G Dimitracopoulos; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

10.  The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages.

Authors:  Z A COHN
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

View more
  2 in total

1.  Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.

Authors:  O Bishop; T Orr; P F Bartell
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

2.  Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement.

Authors:  E Brummer; A M Sugar; D A Stevens
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.